Volume 7, Issue 2 (Summer 2003)                   2003, 7(2): 41-45 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Larijani B, Pajoohi M, Javadi A, Maleckzadeh H, Samavat T, Hojjatzadeh A, et al . Prevalence of diabetes mellitus & impaired glucose tolerance of. Journal of Inflammatory Diseases. 2003; 7 (2) :41-45
URL: http://journal.qums.ac.ir/article-1-239-en.html
Abstract:   (11683 Views)
Background : Diabetes mellitus is a major health problem in all countries. Epidemiologic information about a disease is prerequisite for managing its consequences. Objective : To determine prevalence of diabetes mellitus (DM) or impaired glucose tolerance (IGT). Methods: This cross-sectional study was implemented on a randomly selected group consisting of 1000 adults with ³ 25 years old who underwent clinical and laboratory examinations and filled out predesigned questionnaires. DM & IGT were diagnosed on the basis of World Health Organization (WHO) Criteria & the results were analyzed through fasting plasma glucose & oral tolerance test . Findings: A total number of 1000 screenees were examined. The prevalence of diabetes mellitus was 15.9% in men and 12.7% in women .The difference was statistically meaningful in neither groups. The prevalence rate of IGT was 7% in men and 10.0% in women . The prevalence of diabetes and IGT increased with age (P<0.0001). Just about 37% of the patients were aware of their illness. Conclusion: Diabetes and IGT are virtually a public health problem in Qazvin urban population so that 1 out of each 5 adults is affected by diabetes or IGT. Regular preventive and intervention programs seem essential so as to control this public health problem inQazvin
Full-Text [PDF 248 kb]   (3091 Downloads)    
Type of Study: Research | Subject: Cardiology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb